SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Clinical Development

PAT consultancy formed by Serentec

09-Sep-2004 - Lloyd's Register Serentec has formed a new practice group to provide process analytical technology (PAT) services to pharmaceutical manufacturing clients worldwide.

LION enters cheminformatics market

25-Aug-2004 - Germany's LION bioscience has made a foray into the market for cheminformatics software with a new package designed to help pharmaceutical companies identify, select and priortise compounds, based on data...

Grace expands chromatography business

23-Aug-2004 - WR Grace subsidiary The Separations Group has acquired Alltech International in a move that raises its standing in the manufacture and supply of chromatography products even further.

Glycochemistry firm expands into contract synthesis

18-Aug-2004 - zuChem, a US company specialising in carbohydrate-based chemical supply, has started a new service to provide custom synthesis of these agents.

Cobra sites get MHRA clearance

10-Aug-2004 - Cobra Biomanufacturing has received approval from the UK regulatory authorities for its new clinical trial manufacturing facilities in Oxford as well as its established unit in Keele.

Solutia may sell off pharma business

05-Aug-2004 - The European subsidiary of bankrupt US chemical company Solutia is considering the sale of its pharmaceutical services business.

Coastal Holdings purchase interest in BioSight

04-Aug-2004 - Technology holding company Coastal Holdings, has purchased a significant equity interest in another biotechnology business, adding to its portfolio of acquisitions and investments in the biotechnology and nanotechnology fields.

Pharmaceutical profiles complete microdosing study

02-Aug-2004 - A unique approach to microdosing, providing drug data ahead of schedule and with improved accuracy, could herald a new era in drug development in which human ADME data is involved...

CellFactors enters administration

30-Jul-2004 - UK biotechnology company CellFactors has entered administration following its failure to raise additional funds to further develop its product Skeletex, a biological matrix derived from human cells that induces new...

Ablynx and P&G in Nanobody drug partnership

21-Jul-2004 - Drug discovery company Ablynx is to enter into a partnership with Proctor and Gamble Pharmaceuticals. The agreement will make use of Ablynx's Nanobody platform to develop drug candidates against a...

Jerini to spin off peptide unit

19-Jul-2004 - Drug development company Jerini has transferred its peptide technologies business unit to a wholly owned subsidiary which will continue to provide and develop peptide-based services and products for biomedical research.

Russian company enters docking software sector

09-Jul-2004 - Moscow, Russia-based Quantum Pharmaceuticals is offering pharmaceutical and biotechnology companies the opportunity to test the latest version of its molecular docking software - Quantum 2.0 - at no cost, reports...

BD acquires Atto Bioscience

07-Jul-2004 - BD Biosciences has acquired Atto Bioscience in a deal worth $25 million (€20m), allowing it to enter the emerging high content cell analysis market and enhancing its presence in the...

UK unveils national CMO to support biotech industry

06-Jul-2004 - In the UK, a groundbreaking partnership between government and industry has led to the creation of a National Biomanufacturing Centre, designed to make it easier for fledgling biotechnology companies to...

Coating helps keep clinical trials 'blind'

05-Jul-2004 - Boehringer Ingelheim has been granted a US patent on a way to disguise real and placebo tablets in a clinical trial - without having to resort to placing them in...

Charles River to buy Inveresk for $1.5bn

02-Jul-2004 - Charles River Laboratories has made a $1.5 billion (€1.2bn) bid to acquire Inveresk Research in a deal that will create a contract research powerhouse with nearly $1 billion in annual...

Qiagen sells off nucleic acid unit

02-Jul-2004 - Qiagen has sold off its embattled nucleic acid synthesis business in a management buyout, but has retained a minority stake and all activities relating to RNA interference (RNAi), a potent...

PamGene, Jerini plan kinase alliance

22-Jun-2004 - PamGene International is to combine its microarray platform with Jerini Peptide Technologies' (JPT) peptide libraries to create a series of new products for kinase studies.

Try outsourcing to control spiralling R&D budgets

16-Jun-2004 - Companies developing new drugs for the global market must deal with the rising costs of the R&D process - and outsourcing may well be the best route, according to Dr...

Informatics firm achieves profit milestone

11-Jun-2004 - Despite a dip in the fortunes of the biotechnology industry, bioinformatics firm BlueGnome has achieved profit in less than three years since its formation. The firm's fortunes are in contrast...

New R&D service firm eyes Asia

09-Jun-2004 - International R&D group SRI has set up a new company to harvest the growing number of new therapeutic agents in development at bioresearch laboratories in Asia.

Ascenion mediate technology use agreement

02-Jun-2004 - A clear legal basis has been established for the first time which will enable research institutions to use molecular biology techniques for which provate companies have dominant patent positions without...

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...